166 related articles for article (PubMed ID: 12549)
1. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
Agarwal RA; Rastogi RB; Singhal RL
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
[TBL] [Abstract][Full Text] [Related]
2. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
Rastogi RB; Singhal RL
J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
[TBL] [Abstract][Full Text] [Related]
3. MK-771 enhances the turnover of norepinephrine in brain.
Rastogi RB; Singhal RL
Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
[TBL] [Abstract][Full Text] [Related]
4. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
Rastoge RB; Singhal RL
J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
[TBL] [Abstract][Full Text] [Related]
5. Repeated exposure of adult rats to Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase.
Kodavanti PR; Derr-Yellin EC; Mundy WR; Shafer TJ; Herr DW; Barone S; Choksi NY; MacPhail RC; Tilson HA
Toxicol Appl Pharmacol; 1998 Dec; 153(2):186-98. PubMed ID: 9878590
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of tyrosine hydroxylase in functional characteristics of discrete brain nuclei].
Nakahara T; Uchimura H; Hirano M
Yakubutsu Seishin Kodo; 1987 Dec; 7(4):453-61. PubMed ID: 2898187
[No Abstract] [Full Text] [Related]
7. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
Keller HH; Bartholini G
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
[No Abstract] [Full Text] [Related]
8. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
Agarwal RA; Rastogi RB; Singhal RL
Neuroendocrinology; 1977; 23(4):236-47. PubMed ID: 409963
[No Abstract] [Full Text] [Related]
9. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
[TBL] [Abstract][Full Text] [Related]
10. Effect of thyrotropin-releasing hormone on the locomotor and sensitizing effects of cocaine in rats.
Przegaliński E; Papla I; Czepiel K; Wydra K; Nowak E; Lasoń W; Filip M
Neuropeptides; 2004 Feb; 38(1):48-54. PubMed ID: 15003716
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of hypothalamic releasing hormones in animals and men.
Prange AJ; Wilson IC; Breese GR; Lipton MA
Prog Brain Res; 1975; 42():1-9. PubMed ID: 729
[No Abstract] [Full Text] [Related]
12. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
Marek K; Haubrich DR
Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
[No Abstract] [Full Text] [Related]
13. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.
Rastogi RB; Singhal RL; Lapierre YD
Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219
[No Abstract] [Full Text] [Related]
14. A developmental role for catecholamines in Drosophila behavior.
Pendleton RG; Rasheed A; Paluru P; Joyner J; Jerome N; Meyers RD; Hillman R
Pharmacol Biochem Behav; 2005 Aug; 81(4):849-53. PubMed ID: 16051344
[TBL] [Abstract][Full Text] [Related]
15. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity.
Nemeroff CB; Diez JA; Bissette G; Prange AJ; Harrell LE; Lipton MA
Pharmacol Biochem Behav; 1977 Apr; 6(4):467-9. PubMed ID: 18744
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of the neuromodulating effect of peripherally administered thyroliberin on the rat brain].
Misin'sh IP; Klusha VE
Biull Eksp Biol Med; 1986 Jan; 101(1):50-2. PubMed ID: 3080036
[TBL] [Abstract][Full Text] [Related]
18. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo.
Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A
J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
Berger T; Lemmer B
Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
[TBL] [Abstract][Full Text] [Related]
20. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
